ClinicalTrials.gov
ClinicalTrials.gov Menu

TBTC Study 25: Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of Tuberculosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00023426
Recruitment Status : Completed
First Posted : September 10, 2001
Last Update Posted : September 13, 2005
Sponsor:
Collaborator:
VA Office of Research and Development
Information provided by:
Centers for Disease Control and Prevention